Three switches for Germany
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Germany’s Expert Advisory Committee for Prescription has given the green light to three new prescription-to-OTC reclassifications, following a strong show of support by consumers and pharmacists for more switches in the country.
You may also be interested in...
An Expert’s Guide To Switching In Germany, Part 1: Navigating The Reclassification Process
Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, talks exclusively to HBW Insight about prescription-to-OTC switching in Germany and the association’s efforts to improve this process.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.